Elelyso 200 UNT Injection
- RxCUI
- 1292881
- RxNorm name
- Elelyso 200 UNT Injection
- Display name
- Elelyso 200 UNT Injection
- Full name
- Elelyso 200 UNT Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:29
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 022458 | Elelyso | taliglucerase alfa | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ELELYSO | TALIGLUCERASE ALFA | Pfizer Laboratories Div Pfizer Inc | fa3cbd5d-677c-4b19-9032-d9182cb69a83 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | 1292881 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fa3cbd5d-677c-4b19-9032-d9182cb69a83 | Elelyso 200 UNT Injection | PSN | 31 | These highlights do not include all the information needed to use ELELYSO safely and effectively. See full prescribing information for ELELYSO. ELELYSO ® (taliglucerase alfa) for injection, for intravenous use Initial U.S. Approval: 2012 | 20251229 |
| fa3cbd5d-677c-4b19-9032-d9182cb69a83 | taliglucerase alfa 200 UNT Injection [Elelyso] | SBD | 31 | These highlights do not include all the information needed to use ELELYSO safely and effectively. See full prescribing information for ELELYSO. ELELYSO ® (taliglucerase alfa) for injection, for intravenous use Initial U.S. Approval: 2012 | 20251229 |
| fa3cbd5d-677c-4b19-9032-d9182cb69a83 | Elelyso 200 UNT Injection | SY | 31 | These highlights do not include all the information needed to use ELELYSO safely and effectively. See full prescribing information for ELELYSO. ELELYSO ® (taliglucerase alfa) for injection, for intravenous use Initial U.S. Approval: 2012 | 20251229 |